A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers (clinicaltrials.gov) - Oct 7, 2026 - P1 | N=460 | Recruiting | Sponsor: Eli Lilly and Company | Trial primary completion date: Apr 2027 ➔ Sep 2028
First-in-human • Trial primary completion date • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Indolent Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
|